I went in to talk to the oncologist today and she gave us the details on the next method of attack. She is suggesting a standard of care chemotherapy drug, Abraxane (nab paclitaxel) plus Anakinra. Anakinra is a drug that is currently FDA approved for reducing the pain and swelling associated with rheumatoid arthritis. It is an interleukin-1 antagonist. The theory is that IL-1 presence in the body contributes to tumor growth and metastasis. Blocking IL-1 by using an antagonist would have the opposite effect.
Anyhow, I'm waiting to get disqualified... I mean I'm attempting to qualify for this trial. If not, I'll just be doing the Abraxane. I need to get the chemo on board to knock some of this growth back soon.
Click here to see the study sheet.
About Me
- aymztx
- Initially diagnosed June 4, 2009 Invasive Ductal Carcinoma Stage II,Grade II tumor size: 2-3 cm node positive ER/PR postive HER2 Neu - negative Current Diagnosis: Metastatic Invasive Ductal Carcinoma Grade 3 Mets: Scalp/skin, Liver, Spine, Bone ER/PR + HER2/NEU -
praying this is the trial for you!
ReplyDeleteThanks Kim!
ReplyDelete